Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2026-01-02 @ 8:33 AM
Study NCT ID:
NCT04512261
Status:
WITHDRAWN
Last Update Posted:
2022-07-01
First Post:
2020-07-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Sponsor:
Reva Basho
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT2019-21-Basho-TOPAZ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None